111 related articles for article (PubMed ID: 1932571)
1. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues.
Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G
Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571
[TBL] [Abstract][Full Text] [Related]
2. Delta-selective opioid peptides containing a single aromatic residue in the message domain: an NMR conformational analysis.
Crescenzi O; Amodeo P; Cavicchioni G; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
J Pept Sci; 1996; 2(5):290-308. PubMed ID: 9230457
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of casokefamide.
Brantl V; Picone D; Amodeo P; Temussi PA
Biochem Biophys Res Commun; 1993 Mar; 191(3):853-9. PubMed ID: 8466524
[TBL] [Abstract][Full Text] [Related]
4. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
Duchesne D; Naim M; Nicolas P; Baron D
Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402
[TBL] [Abstract][Full Text] [Related]
5. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH
J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
[TBL] [Abstract][Full Text] [Related]
7. Conformational properties of deltorphin: new features of the delta-opioid receptor.
Temussi PA; Picone D; Tancredi T; Tomatis R; Salvadori S; Marastoni M; Balboni G
FEBS Lett; 1989 Apr; 247(2):283-8. PubMed ID: 2541018
[TBL] [Abstract][Full Text] [Related]
8. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
9. New features of the delta opioid receptor: conformational properties of deltorphin I analogues.
Balboni G; Marastoni M; Picone D; Salvadori S; Tancredi T; Temussi PA; Tomatis R
Biochem Biophys Res Commun; 1990 Jun; 169(2):617-22. PubMed ID: 2162669
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
[TBL] [Abstract][Full Text] [Related]
11. Topographical requirements for delta-selective opioid peptides.
Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
13. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.
Erspamer V; Melchiorri P; Falconieri-Erspamer G; Negri L; Corsi R; Severini C; Barra D; Simmaco M; Kreil G
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5188-92. PubMed ID: 2544892
[TBL] [Abstract][Full Text] [Related]
14. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
15. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis.
Riand J; Baron D; Nicolas P; Benajiba A; Teng Y; Naim M
J Biomol Struct Dyn; 1999 Dec; 17(3):445-60. PubMed ID: 10636080
[TBL] [Abstract][Full Text] [Related]
16. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
17. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T
Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595
[TBL] [Abstract][Full Text] [Related]
18. The mu-selective heptapeptide opioid dermorphin has two conformations around Phe3 psi with no head-to-tail interaction. A quantitative 2-D NMR and molecular modeling analysis.
Riand J; Nicolas P; Baron D
J Biomol Struct Dyn; 2002 Dec; 20(3):359-73. PubMed ID: 12437374
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of deltorphin I at 265 K: a quantitative NMR study.
Amodeo P; Motta A; Tancredi T; Salvadori S; Tomatis R; Picone D; Saviano G; Temussi PA
Pept Res; 1992; 5(1):48-55. PubMed ID: 1623303
[TBL] [Abstract][Full Text] [Related]
20. What peptides these deltorphins be.
Lazarus LH; Bryant SD; Cooper PS; Salvadori S
Prog Neurobiol; 1999 Feb; 57(4):377-420. PubMed ID: 10080383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
